Lantern Pharma Inc. (LTRN)
Market Closed
18 Sep, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
1. 55
-0.16
-9.3567%
$
24.63M Market Cap
- P/E Ratio
- Div Yield
190,300 Volume
-2.03 Eps
$ 1.71
Previous Close Investors:
Want to track LTRN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Lantern Pharma Inc. (LTRN) Statistics
Valuation metrics
Market Cap 24.63M
Enterprise value 13.16M
Trailing P/E (ttm) -0.96
Forward P/E -
PEG ratio -0.15
Price/Sales (ttm) -
Price/Book (mrq) -5.99
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.71
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 197.12K
Average volume (90 days) 118.58K
Price summary
52-Week low 1.11
52-Week high 4.7
Beta -
50-Day moving average 1.99
200-Day moving average 2.43
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -2.17%
Return on equity -4.56%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.5
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.59
Total debt (mrq) -
Total Debt/Equity (mrq) -0.01
Current ratio (mrq) 1.96%
Book value per share (mrq) -0.26
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
